Financial Daily from THE HINDU group of publications
Saturday, Apr 08, 2006


Group Sites

Corporate - Announcements

Nicholas Piramal tightens grip to check Phensedyl abuse

P.T. Jyothi Datta

Complaints of people `getting high' on consuming the syrup

Plugging the holes
To prevent abuse the company has included holograms on its package.
Developing a "one-way-valve" to prevent bottles getting re-filled.

Mumbai , April 7

Nicholas Piramal India Ltd is strengthening its efforts to check abuse of its Rs 110-crore cough syrup Phensedyl.

Having witnessed the low-point of sales slipping on Phensedyl due to raids on retailers last year, the drug maker has tightened its grip on the product and its supply-chain.

Faced with complaints of people getting high on "phensedyl", especially in the North-East, and allegations of diverting the product into neighbouring Bangladesh, it has been rough for the popular cough syrup brand. "We have learnt a lot from this episode," says Dr Swati Piramal, NPIL's Director-Strategic Alliances. "We have no sales in Bangladesh, nor a sales office," she responds, to allegations that Phensedyl was being diverted there. "Phensedyl has become a generic name (for cough syrup) like Xerox or Bisleri," she says, adding that cough syrups seized in Bangladesh were in sachets (which NPIL does not make) and litre-packs (which are not allowed by the Indian Government). Makers of spurious-drugs sell re-filled bottles and packets as "phensedyl", she says. Bangladesh has banned cough syrups containing codeine and that increases the problem, says Dr Piramal. "The product is legal in India and countries neighbouring Bangladesh. The borders are porous and poultry and buffaloes cross the border. The ban only creates an unnatural demand for the product allowing people to make money in between," she observes.

NPIL does not sell in the North-Eastern States of India either, with Tripura also having banned codeine-based cough syrups. To prevent further abuse of Phensedyl, NPIL has included holograms on its package, is developing a "one-way-valve" that prevents bottles from getting re-filled and is even working on making the product safe, like that given to children. "We are doing everything to ensure that Phensedyl is sold for the purpose it is prescribed," says Dr Piramal.

It has also roped in non-government organisation Kripa in the North-East to conduct a retrospective study over 10 years, on why people misuse drugs, she said. Kripa will also work with doctors, psychiatrists in the region and from Bangladesh to spread awareness on Phensedyl.

More Stories on : Announcements | Pharmaceuticals | Economic Offences

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
PSL bags Rs 85-cr Oman order

Nicholas Piramal tightens grip to check Phensedyl abuse
L&T gets Chinese co order
`Tatas will dilute stake in Idea at right time, price'
Have IDRs arrived?
Sahara One to raise $50 m
Tatas go hunting on Harvard campus
Bajaj Electricals opens new unit
BAL to decide on Indonesia unit soon
Amara Raja plans expansion
Mankind Pharma's new facility in Himachal
Petronet LNG ties up finances for Dahej expansion
Clause 49: SEBI warns erring cos
Ma Foi to team up with Karachi firm
Canoro Resources to farm out interest to Brownstone Ventures
Corporate meet
Kingfisher Air may set up venture abroad
NEG Micon plans to export turbines next year
Dolphin Offshore eyes EPC contracts for growth
Chemfab promoters to trim holding to 75 pc

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line